JAMA Internal Medicine: Association of COVID-19 Vaccination During Pregnancy With Incidence of SARS-CoV-2 Infection in Infants

Disclaimer: The content, article(s), education, opinions, products and/or services discussed and/or mentioned herein are: Not intended for the general public; Not considered medical, legal, financial, accounting or other professional advice; and to educate physicians, healthcare business leaders and/or healthcare professionals about relevant healthcare news.

JAMA Internal Medicine


Media advisory: The full study is linked to this news release.

Free access to the full-text article: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/10.1001/jamainternmed.2022.2442?guestAccessKey=49ed6d1a-e838-4437-8d88-92f5ae1e1cad&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060122

About The Study: This study of all live births in Norway between September 2021 and February 2022 found that infants born to women who received a second or third COVID-19 vaccine dose during the last two trimesters of pregnancy had a lower incidence of SARS-CoV-2 infection within the first four months of life compared with infants born to unvaccinated women.

Authors: Ellen Øen Carlsen, M.D., of the Norwegian Institute of Public Health in Oslo, Norway, is the corresponding author.


Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email media relations.

SOURCE: https://media.jamanetwork.com/news-item/association-of-covid-19-vaccination-during-pregnancy-with-incidence-of-sars-cov-2-infection-in-infants/